1004794-08-4Relevant academic research and scientific papers
SUBSTITUTED HETEROCYCLIC ETHERS AND THEIR USE IN CNS DISORDERS
-
Page/Page column 30-31, (2009/09/05)
The invention encompasses compounds of Formula I, including pharmaceutically acceptable salts, their pharmaceutical compositions, and their use in treating CNS disorders.
SUBSTITUTED HETEROCYCLIC ETHERS AND THEIR USE IN CNS DISORDERS
-
Page/Page column 27, (2008/06/13)
The invention encompasses compounds of Formula I, including pharmaceutically acceptable salts, their pharmaceutical compositions, and their use in treating CNS disorders.
